• Journal of Pharmaceutical Investigation
• /
• v.10 no.3
• /
• pp.33-45
• /
• 1980

In order to increase the solubility of metoclopramide, various ratio coprecipitates with polyvinylpyrrolidone (M.W. 40,000) were prepared. The experiments of the solubility, physicochemical characteristics were quantitatively developed. The solubility increased as the ratio of rnetoclopramide to polyvinylpyrrolidone in metoclopramide-polyvinylpyrrolindone coprecipitate increased. In powder state, the dissolution rate of metoclopramide-polyvinylpyrrolidone coprecipitate was greater than that of metoclopramide and metoclopramide-polyvinylpyrrolidone physical mixture. Dissolution characteristics of non-disintegrating disk with constant surfacearea was in accord with Noyes-Nernst equation. The intrinsic dissolution rate, G, at $37^{\circ}C$ was $3.98{\times}10^{-7}M/cm^2{\cdot}min$ for metoclopramide, $2.26{\times}10^{-6}\;M/cm^2{\cdot}min$ for 1 : 5 metoclopramide-polyvinylpyrrolidone coprecipitate, respectively. Accordingly, activation energy of metoclopramide was 15,061cal/M, 9,178cal/M for 1 : 5 metoclopramide-polyvinylpyrrolidone coprecipitate and the activation energy decreased as the coprecipitate was formed. X-ray diffraction study revealed the fact that metoclopramide was crystalline, in contrast, there was no crystallinity evident in the 1 : 5 metoclopramide-polyvinylpyrrolidone coprecipitate. There was no difference between physical mixture and coprecipitate in TLC, UV and NMR studies. From the comparision between physical mixture and coprecipitate in IR spectrum, the interaction such as association between metoclopramide and polyvinylpyrrolidone was considered. But the association was easily dissociated in methanol solution.

• YAKHAK HOEJI
• /
• v.23 no.2
• /
• pp.81-94
• /
• 1979

Rifampicin-polyvinylpyrrolidone coprecipitates were prepared by the solvent method to increase the solubility and dissolution rate, thereby improving absorption of rifampicin. It was found that the solubility and dissolution rate were greater with the 1 : 5 (w/w) coprecipitate than with the pure drug, physical mixtures or coprecipitates of any other ratio of the two components. The blood concentration data in non-fasted rats showed that the extent of absorption of rifampicin were significantly enhanced following the oral administration of the 1 : 5 coprecipitate; The area under the serum concentration curve (0-8hr) was 1.3 times greater with the 1 : 5 coprecipitate than with the pure drug. The blood concentration reached its peak (4. 38$\pm$1.36mcg/ml) within two hours in the case of oral administration of the 1 : 5 coprecipitate and, on the other hand, it reached the maximum (3.77$\pm$0.90mcg/ml) after four hours of oral administration of the pure drug. It was observed that there was no significant difference between the 1 : 5 coprecipitate and the pure drug in the extent and rate of absorption of rifampicin when fasted rats were used. When the 1 : 5 coprecipitate was orally administered to human subjects 20 minutes after meal, it was found that the blood concentration reached the maximum after one hour; in the case of the pure drug, it reached its peak after four hours.

• Journal of Pharmaceutical Investigation
• /
• v.14 no.1
• /
• pp.1-10
• /
• 1984

Effects of water soluble carrier on the dissolution characteristics of indomethacin coprecipitates were investigated. Water soluble carriers used were polyvinylpyrrolidone, dextrose, mannitol and their mixtures of various ratios. The dissolution rates of indomethacin from coprecipitate with ratios of drug-to-carrier, kinds of carrier and ratios of carriers were as follows: 1. The dissolution rates increased proportionally to the ratios of carrier in the case of both single and combined carrier, and the dissolution rate of coprecipitate with the combined carrier was more rapid than that with single carrier. 2. The combined carrier of PVP-dextrose (1 : 2) in the case of the coprecipitate of drug-to carrier (1 : 1) and PVP-dextrose (4 : 1) in the case of the coprecipitate of drug-to carrier (1 : 3) yield the most rapid dissolution rate. 3. The dissolution rate of indomethacin was the most markedly enhanced in the case of the combined carrier of PVP and dextrose.

• Journal of Pharmaceutical Investigation
• /
• v.9 no.1
• /
• pp.7-14
• /
• 1979

The relative efficacy on the renal function of rabbits by oral administration of furosemide and 1 : 2 furosemide-PVP coprecipitate was compared by measuring the urine volume in response to maximal response and the amounts of electrolytes excreted in urine. The furosemide produced a rapid onset, short duration of diuresis, in contrast, the 1: 2 furosemide-PVP coprecipitate, a rapid onset, significantly larger magnitude, and longer duration of diuresis and therefore the bioavailability of furosemide from the coprecipitate were increased significantly. The average urine volume and the amount of sodium and potassium excreted in urine were increased about 2.9-, 14.8-, and 1.8-fold from furosemide, and about 6.2-, 24.2-, and 3.6-fold from 1 : 2 furosemide- PVP 40,000 coprecipitate, rerpectively, comparing by their control values.

• Journal of Pharmaceutical Investigation
• /
• v.5 no.4
• /
• pp.17-23
• /
• 1975

복용량이 비교적 적고, 난용성 의약품(醫藥品)으로 antirheumatism에 사용되고 있는 phenylbutazone을 macromolecule polymer로서 water soluble carrier인 polyvinylpyrrolidone과 solvent method로 1:1, 1:5, 및 1:9(w/w)의 coprecipitate를 형성(形成)시켰으며, 이들 coprecipitate의 용출 속도를 Pure drug 및 coprecipitate 형성 용매인methanol에서 재결정한 recrystallized pure drug의 그것과 측정 비교(比較)하였다. 1:1,1:5 및 1:9(w/w)의 coprecipitate는 recrystallized pure phenylbutazone보다 약 4.5배의 용출의 증가를 보였고, 이들 1:1,1:5,1:9(w/w)에서의 그 carrier의 양(量)에 따른 용출에의 영향은 거의 없었다. 시간(時間)에 대(對)한 log probit를 plot하여 구(求)한 dissolution half life, $T_{50%}$는 coprecipitate ratio 1:1(w/w)에서는 5.5분, 1:5에서는 10분, 1:9에서는 12.5분이었다.

• Journal of Pharmaceutical Investigation
• /
• v.20 no.4
• /
• pp.193-198
• /
• 1990

To increase the dissolution rate of furosemide, cogrinding or coprecipitating of furosemide with povidone was carried out. The ground mixture of furosemide with povidone was prepared by cogrinding in a ceramic ball mill and the coprecipitate was prepared by solvent method using methanol. The povidone ground mixture and the coprecipitate showed a faster and more enhanced dissolution rate than the physical mixture or intact furosemide. The IR, DTA and TGA studies showed the physicochemical modifications of furosemide from the ground mixture and the coprecipitate. An interaction, in the ground mixture and in the coprecipitate, such as association between the functional groups of furosemide and povidone might occur in the molecular level. The coprecipitating and cogrinding techniques with povidone provided a promising way to increase the dissolution rate of poorly soluble drugs.

• Journal of Pharmaceutical Investigation
• /
• v.19 no.1
• /
• pp.1-7
• /
• 1989

Coprecipitates of ibuprofen (IPF)-sodium deoxycholate (DC-Na) were prepared at various mixing ratios of IPF to DC-Na. X-ray diffraction measurments indicated that IPF in 1:3 and 1:5 IPF-DC-Na coprecipitate did not exist in the crystal form, however in the 1:8 coprecipitate, IPF remained its crystalline form. The dissolution rate was tested in pH 7.4 phosphate buffer by the paddle method of dissolution test of KP V. The dissolution rates of IPF from 1:1, 1:3, 1:5, 1:8 and 1:10(w/w) IPF-DC-Na coprecipitates and physical mixtures were compared with that of IPF alone. It was found that the dissolution rate of 1:5(w/w) coprecipitate was greater than that of pure IPF, coprecipitate and physical mixture at any other ratios of the two components. The concentration of IPF released from the IPF-DC-Na coprecipitates reached a plateau within 10 min, and thereafter gradually decreased indicating that IPF released from the coprecipitate was recrystallized due to the transient supersaturation.

• Archives of Pharmacal Research
• /
• v.2 no.1
• /
• pp.49-64
• /
• 1979

In an atempt to elucidate further physicochemical properties of furosemide-PVP coprecipitates, extensive investigations such as TLC, UV,IR, NMR, X-ray diffraction, TGA and DTA studies were carried out for the furosemide test systems. X-ray diffraction studies revealed that the pure furosemide and the furosemide contained within a physical mixture were crystalline in nature. However, there was no crystallinity evident in the 1:5 furosemide-PVP 40,000 coprecipitate system, even after standing for two years. The various ratio furosemide-PVP 40,000 coprecipitate systems revealed that the coprecipitate containing a greater amount of PVP 40,000 than that of furosemide showed a crystalline state of furosemide and that the minimum amounts of PVP to make amorphous form of furosemide was 1:1 ratio of furosemide to PVP. From the furosemide-PVP coprecipitate systems with PVP of different molecular weights of 10,000, 40,000 and 360,000, all the 1:1 ratio coprecipitates did not exhibit any crystallinity of furosemide, whereas all the 2:1 ratio coprecipitates showed a presence of crystalline furosemide. All the coprecipitated preparations with PEG 4,000 and with PEG 6,000 showed the diffraction peaks indicating the presence of crystalline furosemide. The comparison of infrared spectra of the physical mixture and the coprecipitate showed an interaction such as association between the functional groups of furosemide and PVP in the molecular level, whereas the studies by TLC, UV and NMR showed its dissociation in methanol solution. The weight losses in TGA curves showed all the same patterns. However, a little different transition form in DTA thermograms was shown between the physical mixture and the coprecipitate, indicating the different thermal property.

• Journal of the Korean Ceramic Society
• /
• v.20 no.4
• /
• pp.340-346
• /
• 1983

The effect of aging coprecipitate obtained by the reaction of mixed solution 1.1 mol FeCl-0.1 mol $BaCl_2$ and 4.0 mol. NaOH-1.0 mol $K _2 CO_3$ on the synthesis process of Baferrite $(BaFe_{12}O_{19})$ was investigated by means of DTA, TGA, XRD and electron microscope. The no-aged coprecipitate seems to be the aggregate of amorphosus $Fe_3$ .$nH_2O$ and (1-X) $BaCO_3$.$xBa(OH)_2$, but the 30 days-aged to be composed of crystalline $Fe_2O_3H_2O$ and $BaCO_3$. The decomposition temperature of $BaCO_3$ in the coprecipitate increases from 400-$700^{\circ}C$ to 700-90$0^{\circ}C$ with increment of aging-time. In the no-aged coprecipitate Ba-ferrite is synthesized through the surface reaction of amorphous Fe_2O_3$ and skeleton crystal BaO at 800-90$0^{\circ}C$ with more compact crystalization. During calcination of the 30 days-aged coprecibitate the intermediate phase BaFe_2O_4$ is formed at 600-$700^{\circ}C$ and completely transformed to Ba-ferrite at 800-90$0^{\circ}C$.

• Journal of Pharmaceutical Investigation
• /
• v.10 no.4
• /
• pp.23-29
• /
• 1980

Ampicillin-polyvinylpyrrolidone coprcipitates, 1 : 5 ratio w/w, were prepared by the solvent method to increase the solubility and dissolution rate of ampicillin anhydrous. It was found that the solubility and dissolution rate of the coprecipitate were higher than that of ampicillin anhydrous, mechanical mixture of ampicillin and polyvinylpyrrolidone in powder state. The intrinsic, dissolution rate, G, are $1.15{\times}10^{-4}\;mole\;cm^{-2}\;min^{-1}$ for the coprecipitate, $1.09{\times}10^{-5}\;mole\;cm^{-2}\;min^{-1}$ for ampicillin anhydrous, and the activation energy of the coprecipitate and ampicillin anhydrous are $9.091{\times}10^3cal/mole$ and $1.854{\times}10^3cal/mole$, respectively.